Stem Cell Banking / Stem Cell Biology and Regenerative Medicine (PDF)

Name: Stem Cell Banking / Stem Cell Biology and Regenerative Medicine
Brand: Springer-Verlag GmbH
SKU: 69835171
Price: 153.99 EUR
Availability: OnlineOnly

(Sprache: Englisch)

Schreiben Sie einen Kommentar zu "Stem Cell Banking / Stem Cell Biology and Regenerative Medicine".

Merken

Mehr zum Inhalt Autorenporträt Video

eBook (pdf) 153.99 €

Buch (Gebunden) 164.99 €

sofort als Download lieferbar

Bestellnummer: 69835171

Printausgabe 164.99 €

eBook (pdf) -7% 153.99 €

Download bestellen

Verschenken

Lastschrift, Kreditkarte, Paypal, Rechnung
Kostenloser tolino webreader

Produktdetails

Produktbeschreibung
Autorenporträt
eBook Hilfe
Biblio. Angaben / Produktdetails

Produktinformationen zu „Stem Cell Banking / Stem Cell Biology and Regenerative Medicine (PDF)“

This volume explores changing global perspectives in banking of cord blood, mesenchymal, embryonic and induced pluripotent stem cells for clinical use. The book is divided into two parts: The first part examines topics including the setting of standards for pluripotent stem cell banking and regulation and ethical issues in stem cell banking. The second part delves into stem cell banking efforts in countries including Japan, Switzerland, India and Iran, among others.

Implementing core values and common standards depend often on specific circumstances of political and economic setting, which makes flexibility as important as systematic planning. Banking of stem cells is not just building a repository and storing samples. The planning, design, construction and maintenance involve multiple skilled professionals. Stem cell banks are points where technology and medicine converge with ethics, laws and regulations. If properly designed and organized, their utilization will have a broad impact not only on the scientific community and medical professionals but also on the general public.

Autoren-Porträt

Dr. Dusko Ilic obtained his MD degree and BSci in Molecular Biology at the University of Belgrade, his PhD at the Tokyo University, Japan and he completed postdoctoral training at the University of California in San Francisco. Before joining King's College School of Medicine in London, he held positions of Adjunct Associate Professor at the University of California San Francisco, Consultant at the Veteran Affairs Medical Center, San Francisco and as Director of R&D at StemLifeLine, a California-licensed stem cell company. Dr. Ilic's current research interests are human embryonic stem (hES) cells, induced pluripotent stem (iPS) cells, and mesenchymal stem cells and their potential in drug discovery and cell-based therapies.